Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...